Institution: University of Alabama

Investigator(s): Dr. Mathew Jarrett

Program: Cogmed RM

Background & Aim: Attention-Deficit/Hyperactivity Disorder (ADHD) presents with various combinations of core symptoms (inattention, hyperactivity, and impulsivity) as well as with co-morbidity with other psychiatric disorders. Most studies have focused on the co-morbidity of ADHD and externalizing disorders such as oppositional defiant disorder (ODD) with fewer studies examining the co-morbidity of ADHD and internalizing disorders (e.g., the anxiety disorders). However, most studies have focused on the treatment of ADHD and anxiety separately despite the co-occurrence of ADHD and anxiety being between 25 and 51 percent. The aim of the current study is to assess the treatment of ADHD and anxiety as a distinct co-morbid subtype of ADHD and to assess the impact of Cogmed on working memory and related neuropsychological functions (ie., response inhibition, attentional breadth) in children with ADHD and anxiety

Population & Sample Size: N = 15 children with ADHD & anxiety in adaptive Cogmed training group, ages 8 -12 years

Design: A-B single case design, Test-retest, 6 month follow-up

To learn more about this research, click here